An inverse association of CREB or MEF2D activation with GFAP expression has been previously described in models of Alzheimer disease 73 or isoflurane neuroprotection in ischemia/reperfusion 74. The gene discussed is GFAP; the disease is early-onset autosomal dominant Alzheimer disease.